Does rituximab really induce hepatitis C virus reactivation?

被引：16

作者：

Ennishi, Daisuke ^{[1
]}

Yokoyama, Masahiro ^{[2
]}

Terui, Yasuhito ^{[2
]}

Takeuchi, Kengo ^{[3
]}

Ikeda, Kazuma ^{[1
,4
]}

Tanimoto, Mitsune ^{[1
,4
]}

Hatake, Kiyohiko ^{[1
,4
]}

机构：

[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Hematol & Oncol, Okayama, Japan

[2] Canc Inst Hosp, Dept Med Oncol & Hematol, Tokyo, Japan

[3] Japanese Fdn Canc Res, Div Pathol, Tokyo, Japan

[4] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Transfus Med, Okayama, Japan

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 28期

关键词：

D O I：

10.1200/JCO.2008.18.7609

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：4695 / 4696

页数：3

共 10 条

[1]

Bermúdez A, 2000, HAEMATOLOGICA, V85, P894

[2]

Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs [J].

Besson, C ;

Canioni, D ;

Lepage, E ;

Pol, S ;

Morel, P ;

Lederlin, P ;

Van Hoof, A ;

Tilly, H ;

Gaulard, P ;

Coiffier, B ;

Gisselbrecht, C ;

Brousse, N ;

Reyes, F ;

Hermine, O .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) :953-960

[3]

Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP [J].

Dai, MS ;

Chao, TY ;

Kao, WY ;

Shyu, RY ;

Liu, TM .

ANNALS OF HEMATOLOGY, 2004, 83 (12) :769-774

[4]

Monitoring serum hepatitis C virus (HCV) RNA in patients with HCV-infected CD20-positive B-cell lymphoma undergoing rituximab combination chemotherapy [J].

Ennishi, Daisuke ;

Terui, Yasuhito ;

Yokoyama, Masahiro ;

Mishima, Yuko ;

Takahashi, Shunji ;

Takeuchi, Kengo ;

Okamoto, Hiroaki ;

Tanimoto, Mitsune ;

Hatake, Kiyohiko .

AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (01) :59-62

[5]

SHORT-TERM PREDNISONE THERAPY AFFECTS AMINOTRANSFERASE ACTIVITY AND HEPATITIS-C VIRUS-RNA LEVELS IN CHRONIC HEPATITIS-C [J].

FONG, TL ;

VALINLUCK, B ;

GOVINDARAJAN, S ;

CHARBONEAU, F ;

ADKINS, RH ;

REDEKER, AG .

GASTROENTEROLOGY, 1994, 107 (01) :196-199

[6]

Rituximab-induced hepatitis C virus reactivation after spontaneous remission in diffuse large B-cell lymphoma [J].

Hsieh, Ching-Yun ;

Huang, Hsin-Hui ;

Lin, Chen-Yuan ;

Chung, Lo Woei ;

Liao, Yu-Mine ;

Bai, Li-Yuan ;

Chiu, Chang-Fang .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15) :2584-2586

[7]

Rituximab chimeric Anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma:: Half of patients respond to a four-dose treatment program [J].

McLaughlin, P ;

Grillo-López, AJ ;

Link, BK ;

Levy, R ;

Czuczman, MS ;

Williams, ME ;

Heyman, MR ;

Bence-Bruckler, I ;

White, CA ;

Cabanillas, F ;

Jain, V ;

Ho, AD ;

Lister, J ;

Wey, K ;

Shen, D ;

Dallaire, BK .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2825-2833

[8]

Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder. [J].

Suzan, F ;

Ammor, M ;

Ribrag, V .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (13) :1000-1000

[9]

Tsutsumi Yutaka, 2005, Expert Opin Drug Saf, V4, P599, DOI 10.1517/14740338.4.3.599

[10]

Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus [J].

Vento, S ;

Cainelli, F ;

Mirandola, F ;

Cosco, L ;

DiPerri, G ;

Solbiati, M ;

Ferraro, T ;

Concia, E .

LANCET, 1996, 347 (8994) :92-93

← 1 →